BALM4 Stock Overview
Engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Baumer S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$11.00 |
| 52 Week High | R$11.90 |
| 52 Week Low | R$9.70 |
| Beta | 0.41 |
| 1 Month Change | 1.85% |
| 3 Month Change | 7.84% |
| 1 Year Change | 3.29% |
| 3 Year Change | -11.86% |
| 5 Year Change | 10.00% |
| Change since IPO | 3,573.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| BALM4 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | -3.6% | -1.6% | -1.2% |
| 1Y | 3.3% | 7.1% | -13.6% |
Return vs Industry: BALM4 underperformed the BR Medical Equipment industry which returned 7.1% over the past year.
Return vs Market: BALM4 exceeded the BR Market which returned -13.6% over the past year.
Price Volatility
| BALM4 volatility | |
|---|---|
| BALM4 Average Weekly Movement | 8.5% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in BR Market | 9.8% |
| 10% least volatile stocks in BR Market | 3.0% |
Stable Share Price: BALM4's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: BALM4's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | n/a | Ruy Salvari Baumer | www.baumer.com.br |
Baumer S.A. engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil. The company offers drugs for bone regeneration, including membrane and graft; and equipment for safe environment, disinfection, preparing and inspecting, water treatment, sterilization, transfer, storage, transport, surgical room, and cleaning. It also provides orthopedic devices, such as conventional prosthesis, non-conventional prosthesis, trauma, neurosurgery, and bone cement.
Baumer S.A. Fundamentals Summary
| BALM4 fundamental statistics | |
|---|---|
| Market cap | R$117.41m |
| Earnings (TTM) | R$9.57m |
| Revenue (TTM) | R$178.51m |
11.3x
P/E Ratio0.6x
P/S RatioIs BALM4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BALM4 income statement (TTM) | |
|---|---|
| Revenue | R$178.51m |
| Cost of Revenue | R$68.92m |
| Gross Profit | R$109.59m |
| Other Expenses | R$100.03m |
| Earnings | R$9.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.98 |
| Gross Margin | 61.39% |
| Net Profit Margin | 5.36% |
| Debt/Equity Ratio | 10.7% |
How did BALM4 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield-126%
Payout RatioDoes BALM4 pay a reliable dividends?
See BALM4 dividend history and benchmarks| Baumer dividend dates | |
|---|---|
| Ex Dividend Date | Dec 20 2024 |
| Dividend Pay Date | Feb 27 2025 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 55 days |
Does BALM4 pay a reliable dividends?
See BALM4 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 06:30 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Baumer S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|